Becton Dickinson and Co

BDX

201.740USD

-4.300-2.09%

Close 01/23, 16:00（ET）Quotes delayed by 15 min

Becton Dickinson and Co's Score

Industry at a Glance

Industry Ranking

3 / 205

Overall Ranking

44 / 4546

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Becton Dickinson and Co Highlights

StrengthsRisks

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 21.84B.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 71.28%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 71.28%.

Undervalued

The company’s latest PE is 35.32, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 268.89M shares, increasing 0.03% quarter-over-quarter.

Held by Ray Dalio

Star Investor Ray Dalio holds 9.50K shares of this stock.

Analyst Rating

Based on 14 analysts

Buy

Current Rating

208.213

Target Price

+2.37%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current financial score of Becton Dickinson and Co is 8.98, ranking 21 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 5.89B, representing a year-over-year increase of 8.35%, while its net profit experienced a year-over-year increase of 23.25%.

Score

Industry at a Glance

Previous score

8.98

Change

0



Financials

6.20

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

9.86

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

9.73

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

9.10

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

The current valuation score of Becton Dickinson and Co is 7.31, ranking 96 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 35.32, which is 65.78% below the recent high of 58.55 and 13.69% above the recent low of 30.49.

Score

Industry at a Glance

Previous score

7.31

Change

0

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 3/205

Relevant data have not been disclosed by the company yet.

The current earnings forecast score of Becton Dickinson and Co is 7.00, ranking 149 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 201.92, with a high of 265.34 and a low of 183.00.

Score

Industry at a Glance

Previous score

7.00

Change

0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

The current price momentum score of Becton Dickinson and Co is 9.05, ranking 32 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 212.71 and the support level at 195.92, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

9.04

Change

0.01

Support & Resistance

Relevant data have not been disclosed by the company yet.

Institutional Confidence

Currency: USD Updated: 2026-01-22

The current institutional shareholding score of Becton Dickinson and Co is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 98.17%, representing a quarter-over-quarter decrease of 0.83%. The largest institutional shareholder is The Vanguard, holding a total of 32.31M shares, representing 11.34% of shares outstanding, with 16.61% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

32.31M

+0.44%

T. Rowe Price Investment Management, Inc.

16.23M

+0.33%

BlackRock Institutional Trust Company, N.A.

14.77M

-2.51%

State Street Investment Management (US)

13.87M

+3.42%

First Eagle Investment Management, L.L.C.

Star Investors

10.00M

+13.74%

MFS Investment Management

8.29M

+7.85%

Geode Capital Management, L.L.C.

6.83M

+1.60%

Wellington Management Company, LLP

5.23M

+9056.29%

Putnam Investment Management, L.L.C.

5.06M

+441.23%

ClearBridge Investments, LLC

4.39M

+15.47%



1

2



The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Becton Dickinson and Co is 9.33, ranking 11 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.24. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Becton Dickinson and Co’s latest ESG disclosure is at an average level in the Healthcare Equipment & Supplies industry, showing no material impact on overall risk.

Becton Dickinson and Co

BDX

8.48 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Thermo Fisher Scientific Inc

TMO

8.59 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

LivaNova PLC

LIVN

8.54 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Castle Biosciences Inc

CSTL

8.45 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Tactile Systems Technology Inc

TCMD

8.44 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

BioLife Solutions Inc

BLFS

8.35 /10

Score

Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment